SCHEMBL6984844

SCHEMBL6984844

CCCCCCCCOC(=O)NC(=N)c1ccc(CCC(=O)N2CCCc3cc(N(CC(=O)OCC)S(=O)(=O)c4ccccc4)ccc32)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP2 O75604 2/20 0.39
MAPK1 P28482 2/20 0.39
ADRB2 P07550 2/20 0.38
ADRB1 P08588 2/20 0.38
ADRB3 P13945 2/20 0.38
LMNA P02545 4/20 0.37
POLB P06746 2/20 0.37
GAA P10253 1/20 0.37
NR3C1 P04150 1/20 0.36
MAPT P10636 3/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
TP53 P04637 2/20 0.36
PDK1 Q15118 1/20 0.36
PDK2 Q15119 1/20 0.36
PDK3 Q15120 1/20 0.36
PDK4 Q16654 1/20 0.36
HTT P42858 2/20 0.35
HPGD P15428 1/20 0.35
ALDH1A1 P00352 2/20 0.35
TSHR P16473 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6979171 0.92 USP2 (0.41) USP2MAPK1LMNAPOLBGAA
SCHEMBL6984183 0.87 F2 (0.40) MAPK1POLBGAANR3C1SMN1; SMN2
SCHEMBL6985778 0.86 NR3C1 (0.43) USP2MAPK1LMNAPOLBGAA
SCHEMBL6978633 0.84 RORC (0.36) LMNAPOLBNR3C1MAPTTP53
SCHEMBL6984049 0.83 NR3C1 (0.52) ADRB2ADRB1ADRB3LMNANR3C1
SCHEMBL7089638 0.83 PARP1 (0.36) LMNAPOLBGAANR3C1TP53
SCHEMBL6984846 0.83 USP2 (0.38) USP2MAPK1ADRB2ADRB1ADRB3
SCHEMBL6987763 0.81 NR3C1 (0.47) USP2MAPK1LMNAPOLBGAA
SCHEMBL7960542 0.81 F2 (0.41) MAPK1POLBGAAMAPTSMN1; SMN2
SCHEMBL6984478 0.79 F2 (0.42) POLBGAAMAPTTP53PDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0991624-B1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA (DE) 2003-11-19 EP disclosed
US-6300342-B1 FOR THERAPY OR INHIBITING THROMBUS FORMATION; FOR THERAPY OF FIBRIN-DEPENDENT INFLAMMATORY CONDITION BOEHRINGER INGELHEIM PHARM KG (DE) 2001-10-09 US disclosed
EP-0991624-A1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT Boehringer Ingelheim Pharma KG (DE) 2000-04-12 EP disclosed
WO-1999000371-A1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA KG (DE) 1999-01-07 WO disclosed